Regeneron Pharmaceuticals, Inc.

Vanguard Personalized Indexing Management, LLC REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

11,973

Value ($000)

9,242

Weight

0.1%

2020 Q1 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	9,242	0.1%	11,973	12/31/2025
2025 Q3	10/31/2025	6,226	0.1%	11,072	9/30/2025
2025 Q2	7/25/2025	5,699	0.1%	10,853	6/30/2025
2025 Q1	5/14/2025	6,381	0.1%	10,061	3/31/2025
2024 Q4	2/10/2025	7,259	0.1%	10,191	12/31/2024
2024 Q3	11/12/2024	11,148	0.2%	10,605	9/30/2024
2024 Q2	8/12/2024	10,047	0.2%	9,559	6/30/2024
2024 Q1	5/9/2024	8,114	0.2%	8,430	3/31/2024
2023 Q4	2/8/2024	7,065	0.2%	8,044	12/31/2023
2023 Q3	11/8/2023	6,558	0.2%	7,969	9/30/2023
2023 Q2	7/28/2023	5,144	0.2%	7,159	6/30/2023
2023 Q1	5/10/2023	5,674	0.2%	6,906	3/31/2023
2022 Q4	2/10/2023	4,579	0.2%	6,346	12/31/2022
2022 Q3	11/14/2022	4,267	0.2%	6,194	9/30/2022
2022 Q2	8/12/2022	3,090	0.1%	5,228	6/30/2022
2022 Q1	5/16/2022	2,757	0.1%	3,947	3/31/2022
2021 Q4	2/23/2022	1,756	0.1%	2,781	12/31/2021
2021 Q3	11/9/2021	1,416	0.1%	2,340	9/30/2021
2021 Q2	8/11/2021	1,049	0.1%	1,879	6/30/2021
2021 Q1	4/28/2021	573	0.1%	1,212	3/31/2021
2020 Q4	1/20/2021	578	0.1%	1,196	12/31/2020
2020 Q3	10/26/2020	696	0.2%	1,244	9/30/2020
2020 Q2	7/27/2020	686	0.3%	1,100	6/30/2020
2020 Q1	5/13/2020	508	0.3%	1,041	3/31/2020